Glycyrrhizin-modified glycosylation and blocked sialylation of hepatitis B surface antigen (HBsAg) [103] . An in vitro study, measuring the release of surface protein (HBsAg) and HBV-DNA in transfected HepG2 2.2.15 cells, showed that this compound had a moderate ability in reducing viral production [104] .